Methods for limiting development of a skin wound
AssigneeUniversity of Southern California
InventorsKathleen E. Rodgers, Gere S. diZerega
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for limiting development of skin wounds, and also for treatment of one or more of erythemas, blisters, rashes, pruritis, contact dermatitis, psoriasis, eczema, acne, and athlete's foot.
Claims28
A method for limiting development of a skin wound, comprising administering to a subject at risk of developing a wound an amount effective of a polypeptide comprising angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof, AII AT2 type 2 receptor agonists, or an agonist (polypeptide or otherwise) of the MAS receptor.
A method for treating erythemas, blisters, rashes, and/or pruritis, comprising administering to a subject in need thereof an amount effective of a polypeptide comprising angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof, AII AT2 type 2 receptor agonists, or an agonist (polypeptide or otherwise) of the MAS receptor, to treat the erythema, blister, rash, and/or pruritis.
A method for treating a disorder selected from the group consisting of contact dermatitis, psoriasis, eczema, acne, and athlete's foot, comprising administering to a subject in need thereof an amount effective of a polypeptide comprising angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof, AII AT2 type 2 receptor agonists, or an agonist (polypeptide or otherwise) of the MAS receptor, to treat the disorder.
Dependencies are inferred from the claim text.